Elevated soluble-St2 concentrations in preeclampsia correlate with echocardiographic parameters of diastolic dysfunction and return to normal values one year after delivery

References

• Duley L. The global impact of preeclampsia and eclampsia. Semin Perinatol. 2009;33:130–137.
   PubMed Web of Science ®Google Scholar
• Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. NICE clinical Guideline 107. London, United Kingdom: Royal College of Obstetricians and Gynaecologists; 2011. Available from: http://www.nice.org.uk/guidance/cg107/evidence/full-guideline-134794333.
   Google Scholar
• American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013. [cited 2019 Feb 28]. Available from: http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Hypertension-in-Pregnancy.
   Google Scholar
• Melchiorre K, Sharma R, Thilaganathan B. Cardiovascular implications in preeclampsia. Circulation. 2014;130(8):703–714.
   PubMed Web of Science ®Google Scholar
• Fraser A, Nelson SM, Macdonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age. Circulation. 2012;125(11):1367–1380.
   PubMed Web of Science ®Google Scholar
• Skjaerven R, Wilcox AJ, Klungsøyr K, et al. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. Br Med J. 2012;345(1):e7677–e7677:e7677.
   Google Scholar
• Romundstad PR, Magnussen EB, Smith GD, et al. Hypertension in pregnancy and later cardiovascular risk? Circulation. 2010;122(6):579–584.
   PubMed Web of Science ®Google Scholar
• Männistö T, Mendola P, Vääräsmäki M, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127(6):681–690.
   PubMed Web of Science ®Google Scholar
• Hermes W, Franx A, van Pampus MG, et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. Am J Obstet Gynecol. 2013;208(6):474.e1–474.e8.
   Web of Science ®Google Scholar
• Charlton F, Tooher J, Rye KA, et al. Cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ. 2014;23(3):203–212.
   PubMed Web of Science ®Google Scholar
• Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health. Circ Cardiovasc Qual Outcomes. 2017;10(2):e003497.
   PubMed Web of Science ®Google Scholar
• Bujold E, Romero R, Chaiworapongsa T, et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonat Med. 2005;18(1):9–16.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Gotsch F, et al. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age. J Matern Fetal Neonatal Med. 2008;21(1):41–52.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Tarca AL, et al. A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia. Am J Obstet Gynecol. 2010;202(6):550.e1–550.e10.
   PubMed Web of Science ®Google Scholar
• Benton SJ, Hu Y, Xie F, et al. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays. Am J Obstet Gynecol. 2011;205(5):469.e1–469.e8.
   PubMed Web of Science ®Google Scholar
• Ghosh SK, Raheja S, Tuli A, et al. Serum PLGF as a potential biomarker for predicting the onset of preeclampsia. Arch Gynecol Obstet. 2012;285(2):417–422.
   PubMed Web of Science ®Google Scholar
• Hagmann H, Thadhani R, Benzing T, et al. The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem. 2012;58(5):837–845.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci. 2012;122(2):43–52.
   PubMed Web of Science ®Google Scholar
• Sibai B, Romero R, Klebanoff MA, et al. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol. 2009;200(6):630.e1–630.e8.
   Web of Science ®Google Scholar
• Romero R, Kusanovic JP, Than NG, et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol. 2008;199(2):122.e1–122.e11.
   Web of Science ®Google Scholar
• Spaan J, Peeters L, Spaanderman M, et al. Cardiovascular risk management after a hypertensive disorder of pregnancy. Hypertension. 2012;60(6):1368–1373.
   PubMed Web of Science ®Google Scholar
• Shah RV, Januzzi JL. ST2: a novel remodeling biomarker in acute and chronic heart failure. Curr Heart Fail Rep. 2010;7(1):9–14.
   PubMedGoogle Scholar
• Rehman SU, Mueller T, Januzzi JL. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol. 2008;52(18):1458–1465.
   PubMed Web of Science ®Google Scholar
• Ky B, French B, McCloskey K, et al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail. 2011;4(2):180–187.
   PubMed Web of Science ®Google Scholar
• Kohli P, Bonaca MP, Kakkar R, et al. Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial. Clin Chem. 2012;58(1):257–266.
   PubMed Web of Science ®Google Scholar
• Socrates T, deFilippi C, Reichlin T, et al. Interleukin family member ST2 and mortality in acute dyspnoea. J Intern Med. 2010;268(5):493–500.
   PubMed Web of Science ®Google Scholar
• Stampalija T, Chaiworapongsa T, Romero R, et al. Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. J Matern Fetal Neonatal Med. 2013;26(14):1359–1370.
   PubMed Web of Science ®Google Scholar
• Romero R, Chaemsaithong P, Tarca AL, et al. Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia – a longitudinal study. J Matern Fetal Neonatal Med. 2018;31(4):418–432.
   PubMed Web of Science ®Google Scholar
• Granne I, Southcombe JH, Snider JV, et al. ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS One. 2011;6(9):e24463.
   PubMed Web of Science ®Google Scholar
• Ambrozic J, Brzan Simenc G, Prokselj K, et al. Lung and cardiac ultrasound for hemodynamic monitoring of patients with severe pre-eclampsia. Ultrasound Obstet Gynecol. 2017;49(1):104–109.
   PubMed Web of Science ®Google Scholar
• Rafik Hamad R, Larsson A, Pernow J, et al. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens. 2009;27(11):2257–2264.
   PubMed Web of Science ®Google Scholar
• Shahul S, Medvedofsky D, Wenger JB, et al. Circulating antiangiogenic factors and myocardial dysfunction in hypertensive disorders of pregnancy. Hypertension. 2016;67(6):1273–1280.
   PubMed Web of Science ®Google Scholar
• Vaddamani S, Keepanasseril A, Pillai AA, et al. Maternal cardiovascular dysfunction in women with early onset preeclampsia and late onset preeclampsia: a cross-sectional study. Pregnancy Hypertens. 2017;10:247–250.
   PubMed Web of Science ®Google Scholar
• Melchiorre K, Sutherland GR, Watt-Coote I, et al. Severe myocardial impairment and chamber dysfunction in preterm preeclampsia. Hypertens Pregnancy. 2012;31(4):454–471.
   PubMed Web of Science ®Google Scholar
• Connelly KA, Prior DL, Kelly DJ, et al. Load-sensitive measures may overestimate global systolic function in the presence of left ventricular hypertrophy: a comparison with load-insensitive measures. Am J Physiol Heart Circ Physiol. 2006;290(4):H1699–H1705.
   PubMed Web of Science ®Google Scholar
• Bamfo JE, Kametas NA, Chambers JB, et al. Maternal cardiac function in normotensive and pre-eclamptic intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;32(5):682–686.
   PubMed Web of Science ®Google Scholar
• Melchiorre K, Sutherland GR, Baltabaeva A, et al. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension. 2011;57(1):85–93.
   PubMed Web of Science ®Google Scholar
• Shahul S, Rhee J, Hacker MR, et al. Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ Cardiovasc Imaging. 2012;5(6):734–739.
   PubMed Web of Science ®Google Scholar
• Cong J, Fan T, Yang X, et al. Maternal cardiac remodeling and dysfunction in preeclampsia: a three-dimensional speckle-tracking echocardiography study. Int J Cardiovasc Imaging. 2015;31(7):1361–1368.
   PubMed Web of Science ®Google Scholar
• Melchiorre K, Thilaganathan B. Maternal cardiac function in preeclampsia. Curr Opin Obstet Gynecol. 2011;23(6):440–447.
   PubMed Web of Science ®Google Scholar
• Orabona R, Vizzardi E, Sciatti E, et al. Insights into cardiac alterations after pre-eclampsia: an echocardiographic study. Ultrasound Obstet Gynecol. 2017;49(1):124–133.
   PubMed Web of Science ®Google Scholar
• Attalla W, Gaber R, Bayomy S. Detection of early left ventricular dysfunction in patients with maternal placental syndrome using tissue Doppler and strain rate imaging. Hypertens Pregnancy. 2015;34(1):80–89.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14.
   PubMed Web of Science ®Google Scholar
• Clancy DJ, Slama M, Huang S, et al. Detecting impaired myocardial relaxation in sepsis with a novel tissue Doppler parameter (septal e′/s′). Crit Care. 2017;21(1):175.
   PubMed Web of Science ®Google Scholar
• Kong W, Gong Y, Zhou R, et al. Soluble ST2, a preeclampsia-related cytokine receptor, is transported bi-directionally across the placenta. Placenta. 2018;63:21–25.
   PubMed Web of Science ®Google Scholar
• Pelà G, Regolisti G, Coghi P, et al. Effects of the reduction of preload on left and right ventricular myocardial velocities analyzed by Doppler tissue echocardiography in healthy subjects. Eur J Echocardiogr. 2004;5(4):262–271.
   PubMedGoogle Scholar
• Hurrell DG, Nishimura RA, Ilstrup DM, et al. Utility of preload alteration in assessment of left ventricular filling pressure by Doppler echocardiography: a simultaneous catheterization and Doppler echocardiographic study. J Am Coll Cardiol. 1997;30(2):459–467.
   PubMed Web of Science ®Google Scholar
• Alma LJ, Bokslag A, Maas AHEM, et al. Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis. ESC Heart Fail. 2017;4(2):88–98.
   PubMed Web of Science ®Google Scholar
• Melchiorre K, Sharma R, Khalil A, et al. Maternal cardiovascular function in normal pregnancy: evidence of maladaptation to chronic volume overload. Hypertension. 2016;67(4):754–762.
   PubMed Web of Science ®Google Scholar